News and Events

The spread of the zika virus in certain countries of the world has caused enormous concern and has led to an avoidable scare in the national and international media.  Dr. Vivekanand Jha, Executive Director of the George Institute for Global Health India, feels that there is no need to panic and provides answers to some frequently asked questions on the zika episode, especially relating to managing vulnerability in countries like India.

Researchers from The George Institute for Global Health, China, have received major new appointments in international professional organizations as acknowledgement for their contributions to combating the burden of non-communicable diseases (NCDs) globally. 

"We urgently need to move away from archaic models of care and work out what an optimal, 21st century healthcare system looks like."

Three researchers from The George Institute for Global Health have been named among the world’s most influential scientific minds in a new report by Thomson Reuters.

Principal Director of The George Institute for Global Health, Professor Stephen MacMahon, has spoken to Australia’s ABC 7.30 on what opportunities exist for Australia as China opens up its health care sector to foreign investment.

Media release: 

Exercise, alone or in combination with education, is effective for preventing lower back pain. That is the central finding in a new study published today in JAMA Internal Medicine

Media release: 

Participation in yoga programs can improve balance, provide a safe and enjoyable form of exercise and may reduce the risk of falls for older Australians, researchers say.

On Christmas Eve of 2015, volunteers from The George Institute China joined with the Chunmiao Foundation to visit children in hospital and their parents.

Media release: 

For the first time, researchers will investigate the burden of fractures in low-middle income countries (LMICs) and describe the current treatment practices in a global multi-centre study, the largest of its kind.

Blood pressure-lowering drugs should be offered to all individuals at high risk of having a heart attack or stroke regardless of their blood pressure at the start of treatment, according to the largest meta-analysis conducted to date involving over 600,000 people, published in The Lancet.